.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers have recently identified structural moral distress as a significant challenge for healthcare leaders during global health emergencies. Nurse middle managers (NMMs) occupy a pivotal position between frontline clinical staff and senior administration. During the COVID-19 pandemic, these professionals faced immense pressure. They had to implement rapidly changing policies while providing constant emotional support to their teams. Consequently, many experienced a unique form of ethical conflict rooted in systemic constraints. This condition often arises when institutional policies prevent leaders from acting according to their professional values.
A qualitative study examined the lived experiences of sixteen nurse middle managers to understand these ethical burdens. Findings revealed that moral distress is a cumulative condition shaped by structural exclusion. For instance, many managers felt excluded from high-level decision-making processes. However, senior leadership still expected them to justify top-down directives to their subordinates. Furthermore, the dual nature of their role created significant ethical ramifications. Managers frequently acted as emotional anchors for their teams without receiving reciprocal support from the organization. As a result, this imbalance weakened their moral agency and personal well-being.
Notably, the study identified three primary themes regarding these ethical tensions. First, the relationship with senior leadership often caused frustration due to a lack of transparency. Second, the pandemic introduced unique dilemmas regarding resource allocation and staff safety. Finally, the conflict between professional values and institutional requirements led to sustained psychological strain. Therefore, addressing structural moral distress is vital for future crisis preparedness. Organizational reforms must focus on strengthening ethical agency and providing better support systems for middle management. By doing so, healthcare systems can enhance their overall resilience during future emergencies.
Moral distress primarily occurs when systemic or institutional constraints prevent a healthcare professional from taking what they believe is the ethically correct action.
Structural exclusion happens when managers are left out of policy decisions but are forced to implement them. This creates a disconnect between their professional values and organizational mandates.
Experts suggest implementing organizational reforms that include NMMs in decision-making and provide dedicated emotional and ethical support systems to prevent burnout.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical or management advice. Refer to the latest local and national guidelines for clinical practice.
References
Fleishman TT et al. Structural moral distress among nurse middle managers in crisis. Nurs Ethics. 2026 May 16. doi: 10.1177/09697330261449300. PMID: 42141893.
Rushton CH. Moral resilience: a capacity for navigating moral distress in critical care. AACN Adv Crit Care. 2016;27(1):111-119.
Morley G, et al. What is ‘moral distress’ in nursing? How, can and should we respond to it? J Clin Nurs. 2019;28(19-20):3343-3345.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A qualitative study highlights the structural moral distress of nurse middle managers during COVID-19, calling for systemic reforms in ethical leadership....
3 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
